Alpha-Lipoic Acid Treatment for Diabetic Vascular Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments fail to effectively reverse or delay diabetes-induced vascular dysfunction, which is characterized by endothelial dysfunction and oxidative stress, leading to complications such as atherosclerosis and hypertension.
Innovation Solution
Administering a therapeutically effective dosage of alpha-lipoic acid to mitigate the negative impact on vascular homeostasis, monitored through biomarker levels and cell assays, which helps in reducing oxidative stress and inflammatory processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for diabetes-related vascular complications, then treatment is provided, but the treatments fail to effectively reverse or delay vascular dysfunction
Solution Approach 1:
The patent changes the biochemical parameter of oxidative stress through alpha-lipoic acid administration, which scavenges reactive oxygen species and restores the balance between oxidation and antioxidant defenses, thereby improving endothelial function and reversing vascular dysfunction in diabetic patients
Solution Approach 2:
Alpha-lipoic acid acts as an intermediary substance that mediates the protective effect against diabetes-induced vascular damage by reducing oxidative stress, improving nitric oxide bioavailability, and activating protective signaling pathways such as PI3K/Akt
2Reliability
If oxidative stress is reduced through antioxidant defenses, then endothelial function improves, but the complexity of treatment increases
Solution Approach 1:
Alpha-lipoic acid enhances the body's endogenous antioxidant defense system by regenerating other antioxidants such as glutathione, vitamin C, and vitamin E, allowing the body's own protective mechanisms to be restored and sustained without requiring complex external intervention systems
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Alpha-lipoic acid treatment significantly reduces oxidative stress and inflammatory markers, improving endothelial function and reversing diabetes-related vascular complications by activating the PI3K/Akt signaling pathway.
Implementation Method 1
Diseased blood vessels produce increased levels of reactive superoxide anion (O2−) and hydrogen peroxide. Superoxide anion reacts with NO, yielding peroxynitrate, which has the potential of inducing protein modification, DNA damage, apoptosis and inflammation.
Implementation Method 2
Oxidative stress in a physiological setting reflects an excessive bioavailability of Reactive Oxygen Species (ROS), which is the net result of an imbalance between production and destruction of ROS, with the latter being influenced by antioxidant defenses, including antioxidant enzyme (e.g., superoxide dismutase, glutathione peroxidase, and catalase) and chemical antioxidants (e.g., α-lipoic acid (LA) and vitamins).
Implementation Method 3
LA and dihydrolipoic acid can scavenge ROS, regenerate other natural antioxidants, such as glutathione, vitamin C and vitamin E, chelate metals ions, and stimulate insulin signaling.
Data Source
AI summary
The method of treating diabetes-related vascular complications includes the treatment of diabetic patients with α-lipoic acid (LA) in order to mitigate the negative impact of diabetes-related vascular dysfunctions upon vascular homeostasis. The treatment method includes the step of administering to the patient an initial dosage of α-lipoic acid believed to be therapeutically effective. The patient's response is then monitored by measuring α-lipoic acid-responsive biomarkers and by performing assays from blood and tissue taken from the patient.